# Naproxen Sodium

NDC: 63941-445
Generic name: NAPROXEN SODIUM
Labeler / Manufacturer: VALU MERCHANDISERS COMPANY
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20240501
Marketing ended: 20280630
FDA application: ANDA079096

## Active ingredients

- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63941-445"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63941-445
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1274889d-803c-d7fd-e063-6394a90ab9a8